Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Intravenous gamma-globulin therapy.

Mandell BF.

J Clin Rheumatol. 1996 Dec;2(6):317-24.

PMID:
19078096
2.

New and controversial uses of intravenous gamma-globulin.

Pahwa RN.

Pediatr Infect Dis J. 1988 May;7(5 Suppl):S34-6.

PMID:
2456509
3.
4.

Clinical uses of intravenous immune globulin.

Knapp MJ, Colburn PA.

Clin Pharm. 1990 Jul;9(7):509-29. Review.

PMID:
2198124
5.

Role of intravenous immunoglobulin G in autoimmune hematologic disorders.

Blanchette VS, Kirby MA, Turner C.

Semin Hematol. 1992 Jul;29(3 Suppl 2):72-82. Review.

PMID:
1509297
6.

Guidelines on the use of intravenous immune globulin for hematologic conditions.

Anderson D, Ali K, Blanchette V, Brouwers M, Couban S, Radmoor P, Huebsch L, Hume H, McLeod A, Meyer R, Moltzan C, Nahirniak S, Nantel S, Pineo G, Rock G.

Transfus Med Rev. 2007 Apr;21(2 Suppl 1):S9-56.

PMID:
17397769
7.

Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases.

Ballow M.

J Allergy Clin Immunol. 1997 Aug;100(2):151-7. Review.

PMID:
9275133
8.

The use of intravenous gamma-globulin in idiopathic thrombocytopenic purpura.

Bussel JB.

Clin Immunol Immunopathol. 1989 Nov;53(2 Pt 2):S147-55. Review.

PMID:
2477185
9.

Use of intravenous immunoglobulin G (IVIG).

Looney RJ, Huggins J.

Best Pract Res Clin Haematol. 2006;19(1):3-25. Review.

PMID:
16377538
11.

Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.

Gürcan HM, Ahmed AR.

Ann Pharmacother. 2007 May;41(5):812-23. Epub 2007 Apr 17. Review.

PMID:
17440006
12.

Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.

Cherin P, Piette JC, Wechsler B, Bletry O, Ziza JM, Laraki R, Godeau P, Herson S.

J Rheumatol. 1994 Jun;21(6):1092-7.

PMID:
7932419
13.

Intravenous immunoglobulin preparations and autoimmune disorders: mechanisms of action.

Ibáñez C, Montoro-Ronsano JB.

Curr Pharm Biotechnol. 2003 Aug;4(4):239-47. Review.

PMID:
14529426
14.

The steroid-sparing effect of intravenous immunoglobulin in patients with autoimmune diseases.

Zandman-Goddard G, Krauthammer A, Shoenfeld Y.

Expert Rev Clin Immunol. 2007 Sep;3(5):773-80. doi: 10.1586/1744666X.3.5.773.

PMID:
20477027
15.

Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.

Sibéril S, Elluru S, Negi VS, Ephrem A, Misra N, Delignat S, Bayary J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV.

Transfus Apher Sci. 2007 Aug;37(1):103-7. Epub 2007 Aug 31. Review.

PMID:
17765663
16.

Intravenous immune globulin therapy for neurologic diseases.

Dalakas MC.

Ann Intern Med. 1997 May 1;126(9):721-30. Review.

PMID:
9139559
17.

[Immunoglobulins--merely expensive or also useful?].

Paar WD.

Ther Umsch. 1995 Oct;52(10):639-44. German.

PMID:
7482374
18.

The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders.

Ballow M.

J Allergy Clin Immunol. 2011 Feb;127(2):315-23; quiz 324-5. doi: 10.1016/j.jaci.2010.10.030. Epub 2010 Dec 24. Review.

PMID:
21185071
19.

Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin.

Soueidan SA, Dalakas MC.

Pediatr Res. 1993 Jan;33(1 Suppl):S95-100. Review.

PMID:
8433882
20.

Intravenous immunoglobulin in the treatment of neurologic disorders.

Živković S.

Acta Neurol Scand. 2015 May 21. doi: 10.1111/ane.12444. [Epub ahead of print]

PMID:
25997034

Supplemental Content

Support Center